LAparoscopic Preventive PRErectal Mesh
Launched by UNIVERSITY HOSPITAL, LILLE · Dec 3, 2018
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
**Trial Summary: Laparoscopic Preventive Prerectal Mesh for Urogenital Prolapse**
This clinical trial is studying a surgical procedure called laparoscopic sacrocolpopexy (LS) to help women with urogenital prolapse, a condition where pelvic organs, like the bladder or uterus, drop from their normal positions. The trial is specifically looking at whether adding a mesh in a certain area (the rectovaginal space) can help prevent future problems with the back wall of the vagina. While the standard surgery has a high success rate, researchers want to see if using this extra mesh can reduce the chance of later issues but also want to weigh this against the risks of complications that may arise from the additional mesh.
To participate in this trial, women must have a specific type of urogenital prolapse but should not have significant issues with the back wall of the vagina. Key criteria for joining include being between the ages of 14 and 27 and being able to read and understand French to provide consent. Participants will undergo the surgery and will be monitored for any complications or improvements in their condition. It's important to note that while this trial aims to explore the benefits of the additional mesh, it also acknowledges potential risks, such as pain or injury. If you or someone you know is affected by urogenital prolapse and meets the criteria, this could be an opportunity to contribute to important research.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women with a urogenital prolapse (anterior wall and/or uterus or vaginal apex) stage = 2 (Ba and/or C points ≥ - 1 cm using the POP-Q system),
- • without significant posterior vaginal wall prolapse (Bp \< -1 cm when apical prolapse is reduced using a retractor leaving the posterior vaginal wall free),
- Exclusion Criteria:
- • Previous surgical repair for Pelvic Organ Prolapse
- • Any associated prolapse requiring any non-authorized additional surgical repair (Authorized additional surgical procedures are hysterectomy, ovariectomy, adnexectomy, salpingectomy, myomectomy, or suburethral vaginal tape.)
- • Wish for future pregnancy
- • Lack of health insurance
- • Woman not reading French or unable to consent
- • Woman under law protection
About University Hospital, Lille
University Hospital Lille is a leading academic medical institution dedicated to advancing healthcare through innovative clinical research and patient-centered care. As a prominent sponsor of clinical trials, the hospital leverages its extensive resources, multidisciplinary expertise, and state-of-the-art facilities to facilitate groundbreaking studies across various medical fields. Committed to enhancing therapeutic options and improving patient outcomes, University Hospital Lille collaborates with researchers, healthcare professionals, and industry partners to ensure rigorous scientific standards and ethical practices in all clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dunkerque, , France
Nice, , France
Clermont Ferrand, , France
La Rochelle, , France
Le Mans, , France
Lille, , France
Lille, , France
Nîmes, , France
Poissy, , France
Patients applied
Trial Officials
Jean-Philippe LUCOT, MD,PhD
Principal Investigator
University Hospital, Lille
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials